Macular Degeneration (AMD) and Other Retinal Diseases: World Drug Market 2014-2024

Macular Degeneration (AMD) and OtherMacular Degeneration (AMD) and Other Retinal Diseases: World Drug Market 2014-2024 PR Newswire LONDON, December 4, 2013 Analysis of revenues and R&D prospects for those eye drugs - you explore potentials What's the future for treating disorders of the retina? Visiongain's updated report forecasts those pharma revenues. There you find outlooks for sales growth in that industry. You also explore trends, technologies, therapies, and opportunities. That analysis gives you predictions of revenues to 2024 at overall world market, submarket, product, and national level. Avoid falling behind in data, then, missing business or losing influence. So find what's happening for those ocular medicines. Discover how you can gain. Read on to explore those products and see what their future could be worth. Forecasts and other information to benefit your research and analyses Besides revenue forecasting to 2024, our new work shows historical data, growth rates, and market shares. There you find original analysis. Explore research and development (R&D) too. You also get 36 tables, 38 charts, and two interviews with other authorities. Anyhow, the future appears promising for companies treating those eye disorders. Ophthalmic technology - find growth opportunities and how to help your work That new study lets you investigate the most promising and lucrative treatments for neovascularisation and other rear eye ailments. You explore technologies and applications.